Alexander Mark Schobel

All filings by Alexander Mark Schobel on record concern Aquestive Therapeutics, Inc., in the capacity of senior executive. Between 31 August 2018 and 15 March 2024, the trades on record add up to 51 filings.

In open-market terms, that means 4 purchases worth €72k on one side and 9 sales worth €1.4M on the other. On balance, insiders were net sellers of €1.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 22 share grants and 16 option exercises. In 2024 alone, the filings show no purchases and 2 sales.

A typical purchase (the median) is worth €12k. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 2 October 2024, the filings show a share grant worth €43k in Aquestive Therapeutics, Inc. The most recent open-market purchase was published on 10 June 2022, 1,597 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.